Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway

Overexpressed survivin is associated with worse survival of several types of human tumors. In this study, the antitumor activity of shikonin in non-small-cell lung cancer (NSCLC) by regulating survivin pathway was investigated. Results showed that shikonin inhibited the NSCLC H1299 cell proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haini, Zuo, Junli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590588/
https://www.ncbi.nlm.nih.gov/pubmed/34782853
http://dx.doi.org/10.1155/2021/6435393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590588/
https://www.ncbi.nlm.nih.gov/pubmed/34782853
http://dx.doi.org/10.1155/2021/6435393

Ejemplares similares